ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,800, issued on July 8, was assigned to DNA TWOPOINTO INC. (Newark, Calif.).
"Modifications of mammalian cells using artificial micro-RNA to alter their properties and the compositions of their products" was invented by Jeremy Minshull (Los Altos, Calif.), Ferenc Boldog (Newark, Calif.), Varsha Sitaraman (San Mateo, Calif.) and Maggie Lee (San Jose, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods and compositions for stable genetic modification of cultured mammalian cells. The genetic modifications can be used to produce cultured mammalian cells for therapeutic or diagnostic purposes."
The patent was filed...